175
Participants
Start Date
August 31, 2009
Primary Completion Date
May 31, 2011
Study Completion Date
August 31, 2011
Nepafenac ophthalmic suspension, 0.1% (NEVANAC®)
One drop instilled in the study eye 3 times daily (morning, midafternoon, and bedtime) beginning the day before surgery, continuing on the day of surgery and through the first 90 days following surgery
Nepafenac ophthalmic suspension vehicle
One drop instilled in the study eye 3 times daily (morning, midafternoon, and bedtime) beginning the day before surgery, continuing on the day of surgery and through the first 90 days following surgery
Contact Alcon Call Center For Trial Locations, Fort Worth
Lead Sponsor
Alcon Research
INDUSTRY